| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/17/1995 | CA1334004C Essential fatty acid compositions |
| 01/12/1995 | WO1995001433A1 Protein s deletion variants deficient in c4bp binding activity, but having apc cofactor activity, compositions and therapeutic methods |
| 01/12/1995 | WO1995001175A1 Immunosuppressant and antiallergic compounds, e.g. n-(3-oxohexanoyl) homoserine lactone |
| 01/12/1995 | WO1995001170A2 Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders |
| 01/12/1995 | CA2166289A1 Immunosuppressant and antiallergic compounds e.g. n-(3-oxohexanoyl) homoserine lactone |
| 01/11/1995 | EP0633022A2 Chondroprotective flavones |
| 01/11/1995 | EP0633021A1 Chondroprotective agents |
| 01/11/1995 | EP0632829A1 Thrombin receptor antagonists |
| 01/11/1995 | EP0632809A1 Quinuclidine derivatives as substance p antagonists |
| 01/11/1995 | EP0632726A1 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability |
| 01/11/1995 | EP0544821B1 Indole derivatives as antiallergy and antiinflammatory agents |
| 01/11/1995 | CN1027371C Synthetizing method for inner ester diterpenoid |
| 01/11/1995 | CN1027370C Process for production of thiazole derivatives |
| 01/10/1995 | US5380879 Immunosuppressants |
| 01/10/1995 | US5380747 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 01/10/1995 | US5380738 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents |
| 01/10/1995 | US5380736 Cholecystokinin and gastric antagonist |
| 01/10/1995 | US5380726 Interleukin inhibitors |
| 01/10/1995 | US5380724 Piperazine and homopiperazine derivatives, pharmaceutical compositions containing them and process for preparing same |
| 01/10/1995 | CA2126513A1 Chondroprotective agents |
| 01/10/1995 | CA2126512A1 Chondroprotective agents |
| 01/10/1995 | CA1333852C Moulding contact lenses |
| 01/05/1995 | WO1995000651A1 Recombinant stratum corneum chymotryptic enzyme (scce) |
| 01/05/1995 | WO1995000643A2 Human cell adhesion protein aamp-1 and uses thereof |
| 01/05/1995 | WO1995000543A1 Anti-inflammatory peptides |
| 01/05/1995 | WO1995000516A1 Novel chemical compounds having pde-iv inhibition activity |
| 01/05/1995 | WO1995000514A1 Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 01/05/1995 | WO1995000511A1 Condensed 4-aminopyridines with antirheumatic activity |
| 01/05/1995 | WO1995000507A1 Azolyl-cyclic amine derivatives with immunomodulatory activity |
| 01/05/1995 | WO1995000501A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/05/1995 | WO1995000493A1 Imidazole derivatives as therapeutic agents |
| 01/05/1995 | WO1995000176A1 Compositions for treating hypoxia-associated ocular complications |
| 01/05/1995 | WO1995000169A1 Medical use of stem bromelain protease |
| 01/05/1995 | WO1995000157A1 Therapeutic agent |
| 01/05/1995 | WO1995000148A1 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade |
| 01/05/1995 | WO1995000139A1 Compounds |
| 01/05/1995 | WO1995000136A1 Method for treating hyperkeratosis and diseases mediated by proteases |
| 01/05/1995 | WO1994026263A3 Use of a transition metal complex for the treatment of septic shock |
| 01/05/1995 | WO1994017099A3 BIOLOGICALLY ACTIVE TGF-β1 AND TGF-β2 PEPTIDES |
| 01/05/1995 | CA2364039A1 Use of phenyl heterocycles in the relief or treatment of rheumatoid arthritis, osteoarthritis, fever, pain, headache or dysmenorrhea |
| 01/05/1995 | CA2165794A1 Therapeutic agent |
| 01/05/1995 | CA2165787A1 Medical use of stem bromelain protease |
| 01/05/1995 | CA2165559A1 Human cell adhesion protein aamp-1 and uses thereof |
| 01/05/1995 | CA2164955A1 Method for treating hyperkeratosis and diseases mediated by proteases |
| 01/05/1995 | CA2163888A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/04/1995 | EP0632026A1 Alpha amino acid derivatives, a method for their preparation and pharmaceutical preparations containing them |
| 01/04/1995 | EP0632017A1 N-phenyl-2-cyano-3-hydroxy propenamides, their tautomeres and salts, their use as medicaments and compositions containing them |
| 01/04/1995 | EP0631784A1 Sulphated polysaccharides having anti-inflammatory activity |
| 01/04/1995 | EP0631776A1 Use of beta-naphthoquinone for accelerating the proliferation of endothelial cells and inhibiting no synthases |
| 01/04/1995 | EP0631580A1 PYRIDO 2,3-d]PYRIMIDINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS |
| 01/04/1995 | EP0631501A1 Glycosylation-mediated inhibition of factor x |
| 01/04/1995 | CN1097005A Chemical compounds |
| 01/03/1995 | US5378823 Trophoblastin |
| 01/03/1995 | US5378720 Treatment of rheumatoid arthritis, emphysema, pancreatitis |
| 01/03/1995 | US5378719 Antiarthritic agents; rheumatic diseases |
| 01/03/1995 | US5378699 Treatment of immune diseases, cell proliferation, restenosis and smooth muscle cells |
| 01/03/1995 | CA1333803C .alpha.-substituted 4-(quinolin-2-yl-methoxy)phenylacetic acids and esters |
| 01/03/1995 | CA1333802C Substituted 4-(quinolin-2-yl-methoxy)phenyl-acetic acid derivatives |
| 01/03/1995 | CA1333772C Method of treatment for arthritic and inflammatory diseases |
| 12/31/1994 | CA2127066A1 .alpha.-amino acids derivatives, their preparation process and pharmaceutical compositions containing them |
| 12/28/1994 | EP0630405A1 Novel V28 seven transmembrane receptor |
| 12/28/1994 | EP0630263A1 Pharmaceutical composition having site-specific delivery |
| 12/28/1994 | EP0630252A1 Pharmaceutical preparation based on rhamnolipid against dermatological diseases, e.g. papilloma virus infections |
| 12/28/1994 | EP0630245A1 Protein kinase c inhibitor |
| 12/28/1994 | EP0630239A1 Antipyretic and analgesic methods and compositions containing optically pure r(-) ketoprofen |
| 12/28/1994 | EP0540526B1 Quinuclidine derivatives |
| 12/28/1994 | EP0534995B1 Inclusion compounds of nimesulide with cyclodextrins |
| 12/28/1994 | CN1096787A Sulfur-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism |
| 12/28/1994 | CN1096784A Therapeutic agents |
| 12/28/1994 | CN1096781A Therapeutic agents |
| 12/28/1994 | CN1027133C Dry adsorbates |
| 12/27/1994 | US5376681 Aminocoumaran derivatives, their production and use |
| 12/27/1994 | US5376676 Process of using anti-inflammatory furanones as selective calcium channel inhibitors |
| 12/27/1994 | US5376672 Method for treating tension type headaches or headaches associated with drugs or their withdrawal |
| 12/27/1994 | US5376668 Cholinergic agents as cognition activators in treatment of Alzheimer*s disease |
| 12/27/1994 | US5376667 Derivatives of benzoylecgonine, ecgonine and their multiple pharmacological properties |
| 12/27/1994 | US5376656 Arylpyridazinones |
| 12/27/1994 | US5376647 bisphosphonic acid derivatives, and useful as a bone resorption inhibitor |
| 12/27/1994 | US5376367 Fusion proteins comprising MGF and IL-3 |
| 12/27/1994 | CA1333714C Quinoline ether alkanoic acids for use as inhibitors of leukotriene biosynthesis |
| 12/22/1994 | WO1994029727A1 Inhibiting protein interactions |
| 12/22/1994 | WO1994029341A1 Methods of enhancing bioactivity of chemokines |
| 12/22/1994 | WO1994029337A1 Anti-inflammatory composition and method with des-tyr dynorphin and analogues |
| 12/22/1994 | WO1994029336A1 New peptide derivatives |
| 12/22/1994 | WO1994029335A1 New peptides derivatives |
| 12/22/1994 | WO1994029299A1 Imidazole lipoxygenase inhibitors |
| 12/22/1994 | WO1994029295A1 Heterocyclic derivatives with immunomodulating activity |
| 12/22/1994 | WO1994029291A1 Aniline derivatives |
| 12/22/1994 | WO1994029262A1 Lipoxin compounds |
| 12/22/1994 | WO1994028936A1 Process for the preparation of an oral solid dosage form containing diclofenac |
| 12/22/1994 | WO1994028910A1 Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose |
| 12/22/1994 | WO1994028897A2 Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection |
| 12/22/1994 | WO1994028895A2 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| 12/22/1994 | WO1994028894A1 Lotion |
| 12/22/1994 | WO1994028870A1 Preparations containing silicon dioxide to improve the taste thereof |
| 12/22/1994 | CA2164880A1 Anti-inflammatory composition and method with des-tyr dynorphin and analogues |
| 12/22/1994 | CA2164827A1 Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose |
| 12/22/1994 | CA2164641A1 Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection |
| 12/22/1994 | CA2163905A1 Inhibiting protein interactions |
| 12/22/1994 | CA2160368A1 Preparations containing silicon dioxide to improve the taste thereof |